header
Image from OpenLibrary

Enhancement the Efficiency of Low-Dose Cisplatin by magnetic field for Cancer Treatment / Marwa Ramadan Zaki Elgarhy ; Supervised Monira Mahmoud Rageh , Ebtesam Abdelghany Mohamad , Reem Hassan Elgebaly

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Marwa Ramadan Zaki Elgarhy , 2020Description: 58 P. : charts , facsmailies ; 25cmOther title:
  • تعزيز كفاءة عقار(السيسبلاتين) منخفضة الجرعة بواسطة المجال المغناطيسى فى علاج السرطان [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Science - department of Biophysics Summary: Background: Electromagnetic fields (EMFs) have been regarded as adjuvant therapy for cancer treatment. The aim of this work was to examine the combination therapy for low dose cisplatin and magnetic fields (MF) on Ehrlich carcinoma-bearing mice. Materials and Methods: In this study, a total of 50 female BALB/C mice were equally distributed into five groups. Mice of control group did not receive MF or cisplatin; low and high dose cisplatin groups were injected intraperitoneally (i.p.) with 3 and 6 mg/kg cisplatin respectively at the experimental (1,4 and 8) days. Mice group of cisplatin + MF were injected with a low dose of cisplatin followed by exposure MF (50 Hz, 50 mT) and the MF group was exposed to MF only. The impact of MF and cisplatin on tumor and kidney were evaluated by measuring the activity of superoxide dismutase (SOD) enzyme, the levels of malondialdehyde (MDA) and glutathione (GSH), DNA injury (comet assay), histopathological investigation of tissues and tumor progress. Results: The combination of a low dose of cisplatin with MF were significantly elevated the levels of MDA and reduced GSH and the activity of SOD. Furthermore, it caused a rise in comet parameters and inhibition in tumor growth. Conclusion: Our results reveal that MF enhances the therapeutic efficacy of cisplatin low doses and reduces its nephrotoxicity
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.04.M.Sc.2020.Ma.E (Browse shelf(Opens below)) Not for loan 01010110081248000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.04.M.Sc.2020.Ma.E (Browse shelf(Opens below)) 81248 . CD Not for loan 01020110081248000

Thesis (M.Sc.) - Cairo University - Faculty of Science - department of Biophysics

Background: Electromagnetic fields (EMFs) have been regarded as adjuvant therapy for cancer treatment. The aim of this work was to examine the combination therapy for low dose cisplatin and magnetic fields (MF) on Ehrlich carcinoma-bearing mice. Materials and Methods: In this study, a total of 50 female BALB/C mice were equally distributed into five groups. Mice of control group did not receive MF or cisplatin; low and high dose cisplatin groups were injected intraperitoneally (i.p.) with 3 and 6 mg/kg cisplatin respectively at the experimental (1,4 and 8) days. Mice group of cisplatin + MF were injected with a low dose of cisplatin followed by exposure MF (50 Hz, 50 mT) and the MF group was exposed to MF only. The impact of MF and cisplatin on tumor and kidney were evaluated by measuring the activity of superoxide dismutase (SOD) enzyme, the levels of malondialdehyde (MDA) and glutathione (GSH), DNA injury (comet assay), histopathological investigation of tissues and tumor progress. Results: The combination of a low dose of cisplatin with MF were significantly elevated the levels of MDA and reduced GSH and the activity of SOD. Furthermore, it caused a rise in comet parameters and inhibition in tumor growth. Conclusion: Our results reveal that MF enhances the therapeutic efficacy of cisplatin low doses and reduces its nephrotoxicity

Issued also as CD

There are no comments on this title.

to post a comment.